drugset / Trial / NCT00640393
Safety and Efficacy of Combining nbUVB to Etanercept in Patients
RandomizedParallel-groupSingle-blindTreatment
Summary
This study will provide data on the addition of narrow band ultra violet B (nbUVB) phototherapy to participants who have not shown an excellent response to three months of etanercept.
Timeline
- Start
- 2008-04
- Primary completion
- 2010-02
- Completion
- 2010-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Etanercept | Protein / enzyme biologic | 50 mg | Subcutaneous |